Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1201617 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201339 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1200595 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201087 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL6847530 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201157 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL4937483 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201490 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201058 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1201189 | 1.00 | FDPS (0.44) | FDPSTHRATHRBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903523-A | Liquid crystal material constructed based on cation-pi action and preparation method and application thereof | 西北工业大学 | 2023-10-20 | — | — | CN | disclosed |
| EP-2253634-A9 | LIQUID PORPHYRIN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | Dai Nippon Printing Co., Ltd. (JP) | 2011-06-01 | — | — | EP | disclosed |
| US-20110046366-A1 | LIQUID PORPHYRIN DERIVATIVE, AND METHOD FOR PRODUCING THE SAME | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2253634-A1 | LIQUID PORPHYRIN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | Dai Nippon Printing Co., Ltd. (JP) | 2010-11-24 | — | — | EP | disclosed |
| EP-1107971-B1 | PORPHYRIN DERIVATIVES, THEIR USE IN PHOTODYNAMIC THERAPY AND MEDICAL DEVICES CONTAINING THEM | DESTINY PHARMA LTD (GB) | 2004-11-24 | — | — | EP | disclosed |
| US-6630128-B1 | Insoluble support | DESTINY PHARMA LIMITED (GB) | 2003-10-07 | — | — | US | disclosed |
| EP-1107971-A1 | PORPHYRIN DERIVATIVES, THEIR USE IN PHOTODYNAMIC THERAPY AND MEDICAL DEVICES CONTAINING THEM | Destiny Pharma Limited (GB) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000012512-A1 | PORPHYRIN DERIVATIVES, THEIR USE IN PHOTODYNAMIC THERAPY AND MEDICAL DEVICES CONTAINING THEM | DESTINY PHARMA LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046366-A1 | LIQUID PORPHYRIN DERIVATIVE, AND METHOD FOR PRODUCING THE SAME | PPOX, OR10J3, ORC3 | FDPS 455/4885THRA 2295/4885THRB 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.